期刊文献+

普伐他汀对高糖培养的肾小球系膜细胞增殖和细胞外基质积聚的影响 被引量:2

Effect of pravastatin on extracellular matrix synthesis and degradation in glomerular mesangial cells cultured in high concentration of glucose
下载PDF
导出
摘要 目的:探讨普伐他汀对高糖培养的肾小球系膜细胞(MC)增殖和细胞外基质(ECM)积聚的影响。方法:大鼠MC分别培养在低糖组、高糖组及普伐他汀组。CCK-8测定MC增殖,ELISA法检测细胞培养上清液Ⅳ型胶原(Col-Ⅳ)、纤维连接蛋白(FN)、转化生长因子-β1(TGF-β1)、基质金属蛋白酶组织抑制因子-1(TIMP-1)的分泌情况,明胶酶谱法检测基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)的活性,RT-PCR法检测结缔组织生长因子(CTGF)mRNA的表达。结果:与低糖组相比,高糖能促进Col-Ⅳ、FN合成,抑制MMP-2、MMP-9活性,增加TIMP-1、TGF-β1、CTGF的分泌,而普伐他汀能一定程度上逆转上述现象。结论:普伐他汀能抑制高糖环境下的MC增殖,并通过抑制ECM的合成、促进ECM的降解减少ECM积聚,机制可能与抑制TGF-β1、CTGF有关。 Objective To investigate the effect of pravastatin on the proliferation of glomerular mesangial cells cultured in high concentration of glucose and accumulation of extracellular matrix (ECM). Methods Rat mesangial cells were cultured with low or high concentration of glucose or with pravastatin. Cell proliferation was assessed by CCK- 8, synthesis of FN and Col-Ⅳ and secretion of TGF-β1 and TIMP-1 in the cultured cells were determined by ELISA, MMP-2 and MMP-9 activities were determined by gelatin zymography, and expression of CTGF mRNA was detected by RT-PCR. Results Glucose in high concentration stimulated the synthesis of FN and Col-Ⅳ and the secretion of TGF- β1, CTGF, and TIMP-1, while inhibited MMP-2 and MMP-9 activities. However, pravastatin suppressed these high glucose-induced changes. Conclusion Pravastatin inhibits the mesangial cell proliferation induced by high glucose and reduces deposition of ECM, which may be associated with inhibiting the expressions of TGF-β1 and CTGF.
出处 《实用医学杂志》 CAS 2008年第19期3305-3307,共3页 The Journal of Practical Medicine
基金 温州科技局基金重点项目(编号:Y2004A009)
关键词 糖尿病肾病 细胞外基质 转化生长因子Β 普伐他汀 Diabetic nephropathy Extracellular matrix Transforming growth factor beta Pravastatin
  • 相关文献

参考文献7

  • 1Danesh F R, Kanwar Y S. Modulatory effects of HMG-CoA reductase inhibitors in diabetic mieroangiopathy [J]. FASEB J, 2004, 18(7) : 805-815.
  • 2Liu I, T, Chang H C, Chiang L C, et al. Historic deacetvlase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion [J]. Caneer Res, 2003,63 (12) : 3069-3072.
  • 3Cosio F G. Effects of high glucose concentrations on human mesangial cell proliferation [J]. J Am Soc Nephrol, 1995,5(8) : 1600-1609.
  • 4Mason R M, Wahab N A, Roger M, et al. Extracellular matrix metabolism in diabetic nephropathy [J]. J Am Soe Nephrol, 2003, 14(5) : 1358-1373.
  • 5Song Y, Li C, Cai L. Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation [J]. Exp Mol Pathol, 2004,76 ( 1 ) : 66-75.
  • 6Kim S I, Han D C, Lee H B. Lovastatin inhibits transforming growth factor-β1 expression in diabelic rat glomeruli and cultured rat mesangial cells[J]. J Am Soc Nephrol, 2000,11 ( 1 ) : 80-87.
  • 7Heusinger-Ribeiro J, Fischer B, Goppelt-Struebe M. Differential effects of simvastatin on mesangial cells [J]. Kidney Int, 2004,66 (1):187-195.

同被引文献14

  • 1丁涵露,张建国,朱妙珍,罗向东,梁光萍.高浓度的糖刺激人肾小球内皮细胞表达单核细胞趋化蛋白-1的影响[J].细胞与分子免疫学杂志,2004,20(4):450-453. 被引量:6
  • 2王梅芳,杨林花.MMP-9与冠状动脉粥样硬化[J].临床心血管病杂志,2004,20(11):699-701. 被引量:8
  • 3李慧,邹大进,贾一韬,韦多,季军捷,彭玲.罗格列酮对高糖诱导的大鼠系膜细胞NF-κB活性及MCP-1表达的抑制作用[J].中华内分泌代谢杂志,2005,21(5):469-470. 被引量:7
  • 4Tayehjee M H, Nadar S, Blann A D, et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloprote-inase 1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (AS-COT)[J]. Am J Hypertens.2004,17 ( 9 ) :764-769.
  • 5Mceniery C M, Wallace S, Dakham Z, et al. Matrix metalloproteinase-9 (MMP-9). MMP-2, and serum elastase aetivitv are associated with systolic hypertension and arterial stiffness [J]. Arterioseler Thromb Vasc Biol. 2005, 25 (2) :372-378.
  • 6Malemad C J. Matrix metalloproteinases (MMPs) in health and disease: an overveinw [J]. Front Biosci, 2006, 11 ( 1 ) : 1696-1701.
  • 7Kadoglou N P, Liapis C D. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aorticaneurysms [J]. Curr Med Res Opin, 2004.20(4):419.
  • 8Zhang B, Ye S, Hermann S M, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronaryatheroselerosis [J]. Circulation, 1999,99 (14) : 1788-1794.
  • 9Medley T L, Cole T J, Dart A M, et al. Matrix metalloproteinase-9 genotype influences large artery stiffness through effeets on aortic gene and protein expression [J]. Arterioseler Thromh Vase Biol,2004, 24(8):1479-1484.
  • 10Lee T M, Su S F, Tsai C It. Effeet of pravastatin on proteinuria in patients with well-controlled hypertension [J]. Hypertension, 2002,40( 1 ) :67-73.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部